Modulation of Erythrocyte Membrane Mechanical Function by
-Spectrin Phosphorylation and Dephosphorylation (*)
- From the Department of Biochemistry, Tokyo Women's Medical College, 8-1 Kawada-Cho, Shinjuku-Ku, Tokyo, 162, Japan and the Lawrence Berkeley Laboratory, Life Science Division, University of California, Berkeley, California 94720
Abstract
The mechanical properties of human erythrocyte membrane are largely regulated by submembranous protein skeleton whose principal components are α- and β-spectrin, actin, protein 4.1, adducin, and dematin. All of these proteins, except for actin, are phosphorylated by various kinases present in the erythrocyte. In vitro studies with purified skeletal proteins and various kinases has shown that while phosphorylation of these proteins can modify some of the binary and ternary protein interactions, it has no effect on certain other interactions between these proteins. Most importantly, at present there is no direct evidence that phosphorylation of skeletal protein(s) alters the function of the intact membrane. To explore this critical issue, we have developed experimental strategies to determine the functional consequences of phosphorylation of βspectrin on mechanical properties of intact erythrocyte membrane. We have been able to document that membrane mechanical stability is exquisitely regulated by phosphorylation of β-spectrin by membrane-bound casein kinase I. Increased phosphorylation of β-spectrin decreases membrane mechanical stability while decreased phosphorylation increases membrane mechanical stability. Our data for the first time demonstrate that phosphorylation of a skeletal protein in situ can modulate physiological function of native erythrocyte membrane.
Footnotes
-
↵* This work was supported in part by NIH Grant DK26263. This work was supported by the Director, Office of Energy Research, Office of Basic Energy Science, of the U. S. Department of Energy under Contract No. DE-AC03-76SF00098. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
↵1 The abbreviations used are:
- CKI-7
-
N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide
- PVDF
-
polyvinylidene difluoride.
-
- Received November 2, 1994.
- Revision received December 15, 1994.
- © 1995 by The American Society for Biochemistry and Molecular Biology, Inc.











